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Background: Esophageal candidiasis is a common disease among patients with impaired cell mediated immunity. In the current 
study, we report esophageal candidiasis among patients with various co-morbidities attending the endoscopic unit at the Bugan-
do Medical Centre.
Methods: This retrospective study was conducted from June to September 2015. All data of  the patients who attended the 
endoscopic unit between 2009 and 2014 were retrieved and analyzed.
Results: A total of  622 patients who underwent oesophagogastroduodenoscopy were analyzed.  A slight majority 334/622(53.7%) 
of  patients were female. Out of  622 patients; 35(5.6%) had esophageal candidiasis. Decrease in age (OR 1.1, 95%CI; 1.0-1.1), 
female sex (OR 3.8, 95%CI; 1.1-13.1), drinking alcohol (OR 17.1, 95%CI; 4.9-58.9), smoking (OR 8.3, 95%CI; 1.7-41.0), anti-
biotic use (OR 5.7, 95%CI; 2.0-16.4), positive HIV status (OR 10.3, 95%CI; 4.6-6.0) and presence of  peptic ulcer disease (OR 
13.2, 95%CI; 3.5-49.0) independently predicted esophageal candidiasis.
Conclusion: Patients with a history of  drinking alcohol, smoking, use of  antibiotics and those with chronic diseases such as 
peptic ulcers were at high risk of  developing esophageal candidiasis. Further studies are needed to identify Candida spp. and their 
anti-fungal susceptibility for proper management of  esophageal candidiasis in HIV and non-HIV individuals.
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Background
Esophageal candidiasis (EC) is one of  the major oppor-
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tunistic fungal infections that occur in over 90% of  the 
HIV infected individuals during the course of  their ill-
ness1,2. Esophageal candidiasis has  also been reported 
to occur in 39.1% of  patients receiving anti-cancer treat-
ment3. In HIV negative population, co-morbidities have 
been found to increase the risk of  developing EC4-7. Oth-
er factors that increase the risk of  EC include intensive 
chemotherapy, chronic use of  corticosteroids, antibiotic 
therapy and alcoholism8,9.
In low-income countries, the diagnosis of  EC mainly de-
pends on the clinical presentations; EC commonly pres-
ents with dysphagia, retrosternal chest pain and a feeling 
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of  obstruction in the esophagus upon swallowing. It is 
estimated that 68.6% of  patients with EC present with 
dysphagia10.  In high-income countries, brushing tech-
nique following oesophagogastroduodenoscopy (OGD) 
then culture and sensitivity is routinely performed for 
the diagnoses of  EC  while in low-income countries this 
practice is not routinely done11.   Many studies in low-in-
come countries have focused on esophageal candidiasis 
among HIV infected population. This study investigated 
the magnitude and factors associated with EC among pa-
tients attending the endoscopy unit. In addition, the cases 
of  EC among non-HIV infected population are present-
ed in detail.
Methodology
Study design and period
This retrospective cross-sectional study was conducted 
at the endoscopy unit of  the Bugando Medical Centre 
(BMC) a tertiary hospital in Mwanza, Tanzania. BMC 
endoscopic unit performs a minimum of  80 endoscopic 
procedures per month. It provides endoscopic services 
for approximately 13 million people from eight regions 
in the lake zone of  the country. The study was conducted 
from June 2015 to September 2015. Data from all patients 
attending the endoscopy unit between 19th August 2009 
and 19th September 2014 were extracted and analyzed.
Data collection and study variables
Checklist was used to collect patients’ information from 
hospital files and the endoscopy unit log book. Indepen-
dent variables such as socio-demographic characteristics 
(age, sex, marital status, cigarette smoking and alcohol use) 
and clinical data (corticosteroid use, antibiotic use, HIV 
sero-status, diabetic and history of  peptic ulcer diseases) 
were extracted. In this study the diagnosis of  esophageal 
candidiasis was made during oesophagogastroduodenos-
copy and was defined by the presence of  white or slightly 
yellowish plaque like lesions on the esophageal mucosa as 
described in a previous study12.
Ethical consideration
Ethical clearance to conduct this study was granted by the 
Joint CUHAS/BMC research ethics and review commit-
tee (CREC) with certificate number CREC/045/2014. 
Permission to conduct the study was sought from the en-
doscopy unit and all data was kept confidential.
Data analysis
Data were entered and cleaned using Microsoft Excel 
software and analyzed using STATA Version 11. Age was 
summarized using mean ± standard deviations. Sex, alco-
hol use, smoking, antibiotic use, HIV status and presence 
of  peptic ulcer diseases (PUD) were summarized as pro-
portions. Univariate and multivariate logistic regression 
analysis was done to determine factors associated with 
esophageal candidiasis among patients attending endos-
copy unit. All factors from the literature known to predict 
EC were subjected to multivariate analysis. A p value of  




Of  the 625 patients who attended the endoscopy unit, 
622 patients were enrolled in this study.  Three pa-
tients were excluded because they had no data on clin-
ical presentations or indication for the endoscopy. The 
mean age of  enrolled patients was 41.59 +15.38 years. 
A slightmajority of  patients were female 334(53.7%). A 
total of  396(63.7%) participants were unemployed and 
121(19.5%) had a history of  antibiotic use.  Most of  pa-
tients were HIV negative 554(89.07%) as shown in table 
1. The co-morbidities among the studied population in-
cluded peptic ulcer diseases 85(13.67), diabetics 14(2.25), 
cirrhosis 14(2.25), asthma 5(0.80) and cancer 4(0.64).
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Table 1. Baseline characteristics of the 622 studied participants 
 
Variable Frequency Percentage 
Age* 41.5±15.38   
Sex     
Male 288 46.3% 
Female 334 53.7% 
Occupation     
Employed 226 39.3 
Unemployed 396 63.7 
Alcohol use     
No 524 84.2 
Yes 98 15.8 
Smoking     
No 581 93.4 
Yes 41 6.6 
Clinical presentation     
Epi. Pain 315 50.6 
Upper GI bleeding 233 37.5 
Dysphagia 55 8.8 
Corticosteroid use     
No 618 99.4 
Yes 4 0.6 
Antibiotics use     
No 501 80.5 
Yes 121 19.5 
HIV     
Negative 554 89.1 
Positive 15 2.4 
Unknown 53 8.5 
Diabetic     
No 608 97.7 
Yes 14 2.3 
PUD     
No 537 86.3 
Yes 85 13.7 
        Note; Ep. Pain is epigastric pain, UGIB is upper gastro intestinal bleeding and PUD is peptic  
          ulcer   diseases 
Clinical presentation
Of  622 participants, 315(50.6%) presented at endoscopy 
unit with epigastric pain/abdominal pain, 19(3.05%) with 
dyspepsia, 55(8.84%) presented with dysphagia and 233 
(37.5%) presented with upper gastro-intestinal bleeding.
Prevalence and predictors of  esophageal candidiasis 
Out 622 patients, 35 (5.63%) were diagnosed to have 
esophageal candidiasis. By multivariate logistic regres-
sion analysis: decrease in age OR 1.11, 95% CI; 1.02-1.12; 
p=0.007, sex(OR 3.8, 95% CI; 1.11-13.13; p=0.033), al-
cohol use(OR 17.1, 95%CI; 4.94-58.9; p<0.001), smok-
ing (OR 8.3, 95%CI; 1.68-41; p=0.009), antibiotic use 
(OR 5.74, 95% CI; 2-16.4; p<0.001), positive HIV status 
(OR 10.3, 95%CI; 2.27-45; p<0.001) and having peptic 
ulcer diseases (OR 13.2, 95%CI; 3.53-49; p<0.001) inde-
pendently predicted EC as shown in table 2. 
Note; Ep. Pain : epigastric pain, UGIB: upper gastro intestinal bleeding and PUD : peptic  
          ulcer   diseases, *Mean has been reported 
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Esophageal candidiasis among HIV negative pa-
tients
Of  554 HIV negative patients, 20(3.6%) had EC. The 
common clinical presentation of  the HIV negative pa-
tients with EC was epigastric pain 70% (14/20). Majori-
ty of  HIV negative patients with EC were using alcohol 
70%(14/20) and had a history of  using antibiotics prior 
to endoscopic examinations 55% (11/20) as shown in ta-
ble 3. Common co-morbidities among 20 HIV negative 
patients with EC were peptic ulcer disease 7(35%) and 
diabetes mellitus 6(30%).  Of  the 20 HIV negative pa-
tients with EC, 4 (20%) did not have any co-morbidity 
but reported taking alcohol (table 3).
Table 2:  Factors associated with esophageal candidiasis 
 
Note: PUD is the peptic ulcer diseases 
Variable Univariate Multivariate 
  EC    n (%) OR(95%CI) P value OR(95%CI) P 
Age* 39.4±15.1 1.02(0.99-1.04) 0.386 1.11(1.02-1.12) 0.01 
Sex           
Male (288) 14(4.2) 1       
Female (334) 21(7.3) 1.79(0.89-3.6) 0.0098 3.8(1.11-13.13) 0.033 
Alcohol           
No (524) 14(2.7) 1       
Yes (98) 21(21.43) 9.93(4.8-20) <0.001 17.1(4.94-58.87) <0.001 
Smoking           
No (581) 27(4.7) 1       
Yes(41) 8(19.51) 4.97(2.09-11.79) <0.001 8.3(1.68-41) 0.009 
Antibiotics use           
No (501) 17(3.39) 1       
Yes (121) 18(14.88) 4.97(2.48-9.98) <0.001 5.74(2-16.43) <0.001 
HIV           
Negative (554) 20(3.61) 1       
Positive (15) 8(53.33) 30.51(10.07-92.42) <0.001     
Unknown (53) 7(13.21) 4.06(1.63-10.11) 0.003 10.34(2.27-45) <0.001 
PUD           
No (537) 27(5.03) 1       
Yes (85) 8(9.41) 1.96(0.86-4.47) 0.109 13.17(3.53-49.09) <0.001 
Note: PUD: peptic ulcer diseases 
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Table 3: Characteristics of HIV negative patients with EC 
 
S/number Sex Age Presentation Alcohol Smoking Antibiotic Diabetic Cirrhosis PUD Asthma 
1 Male 20 No No No No No No Yes  
7 Male 40 Ep. pain Yes No Yes No No Yes No 
8 Female 38 Ep. pain Yes No No Yes No No No 
9 Female 47 Ep. pain No No No Yes No No No 
10 Male 77 Ep. pain Yes Yes Yes No No No No 
11 Female 38 Ep. pain No No Yes No No Yes No 
12 Male 34 UGIB Yes Yes No No No Yes No 
13 Female 60 Ep. pain Yes No Yes No No Yes No 
14 Male 28 Ep. pain Yes Yes No No No No No 
15 Male 40 Dysphagia Yes No No Yes No Yes No 
16 Male 36 Ep. pain Yes No Yes Yes No No No 
17 Male 44 UGIB Yes Yes No No Yes No No 
18 Female 62 Ep. pain No No No Yes No No No 
19 Female 33 Ep. pain Yes No Yes No No Yes No 
20 Male 23 Ep. pain No No Yes No No No Yes 
Note; Ep. Pain is epigastric pain and UGIB is upper gastro intestinal bleeding 
Discussion
Esophageal candidiasis is the commonest cause of  esoph-
agitis among HIV infected individual. As documented in 
previous studies2,13, half  of  the patients in the present 
study had epigastric pain (50.6%) This can be explained 
by the possibility that Candida spp. might have caused gas-
tritis14.  Other documented complaints include odyno-
phagia, dysphagia and retrosternal pain2,15.
With improvement of  the endoscopic services, EC has 
been reported in HIV negative patients13,16, as evidenced 
in the current study whereby 3.6% of  HIV negative pa-
tients had EC. In HIV negative patients, the EC is nor-
mally associated with peptic ulcer diseases, diabetes and 
prolonged use of  antibiotics4,  these factors were con-
firmed in the current study.
In diabetic patients, EC is linked with depressed immune 
system and the stasis of  the esophageal content17. Esoph-
ageal candidiasis among patients with PUD is linked to 
the chronic use of  the proton pump inhibitors which lead 
to hypochlorhydria  which in turn alters the stomach bac-
teria flora colonization and increases the risk of  candida 
over growth10,18.  
Use of  broad spectrum antibiotics results in normal flora 
disturbances leading to over growth of  Candida spp. which 
might progress to EC4,10. In the present study patients 
with a history of  antibiotic use had 14 times odds of  get-
ting esophageal candidiasis than patients with no history 
of  antibiotic use. As it was described in other studies18,19, 
alcohol drinking and  smoking were confirmed  in this 
study as predictors  of  getting EC.  This can be explained 
by the fact that alcohol has the effect of  elevating the gas-
tric pH and augmenting  the colonization of  the esopha-
gus by oral cavity bacteria and yeast19.
Despite the significance of  the data presented in this 
study some limitations have been noted; firstly, the study 
was retrospective; hence the risk factors can be under 
estimated, secondly the sensitivity and specificity of  the 
clinical diagnosis of  EC by endoscopy might have affect-
ed the outcome.
Conclusion
Patients with history of  drinking alcohol, smoking, use of  
antibiotics and those with chronic diseases such as peptic 
ulcers are at high odds of  developing esophageal candi-
diasis. Further studies to identify Candida spp. and their 
anti-fungal susceptibility are recommended for proper 
management of  esophageal candidiasis in HIV and non-
HIV individuals.
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